| Literature DB >> 22207161 |
Kumiko Sakai-Kato1, Keiko Ishikura, Yuki Oshima, Minoru Tada, Takuo Suzuki, Akiko Ishii-Watabe, Teruhide Yamaguchi, Nobuhiro Nishiyama, Kazunori Kataoka, Toru Kawanishi, Haruhiro Okuda.
Abstract
New technologies are needed to deliver medicines safely and effectively. Polymeric nanoparticulate carriers are one such technology under investigation. We examined the intracellular trafficking of doxorubicin-bound block copolymers quantitatively and by imaging doxorubicin-derived fluorescence using confocal microscopy. The polymers were internalized by endocytosis and distributed in endosomal/lysosomal compartments and the endoplasmic reticulum; unlike free doxorubicin, the polymers were not found in the nucleus. Moreover, the ATP-binding cassette protein B1 (ABCB1) transporter may be involved in the efflux of the polymer from cells. This drug delivery system is attractive because the endogenous transport system is used for the uptake and delivery of the artificial drug carrier to the target as well as for its efflux from cells to medium. Our results show that a drug delivery system strategy targeting this endogenous transport pathway may be useful for affecting specific molecular targets.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22207161 DOI: 10.1016/j.ijpharm.2011.12.022
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875